The Korean journal of internal medicine

The Korean Association of Internal Medicine (대한내과학회)
권호 표지
DOI QR코드

DOI QR Code

Korean physicians' policies for postoperative surveillance of colorectal cancer

  • Baek, Sun Kyung (Department of Internal Medicine, Kyung Hee University Hospital) ;
  • Lee, Sang-Cheol (Department of Internal Medicine, Soonchunhyang University Cheonan Hospital) ;
  • Kim, Jong Gwang (Department of Oncology/Hematology, Kyungpook National University Medical Center) ;
  • Um, Jun Won (Department of Surgery, Korea University Ansan Hospital) ;
  • Lee, Suk-Hwan (Department of Surgery, Kyung Hee University Hospital at Gangdong) ;
  • Jang, Byung Ik (Department of Internal Medicine, Yeungnam University College of Medicine) ;
  • Park, Jae Jun (Department of Internal Medicine, Yonsei University College of Medicine) ;
  • Kim, Tae Won (Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine)
  • Received : 2016.07.07
  • Accepted : 2016.10.07
  • Published : 2018.07.01
⟨ Previous Next ⟩

Abstract

Background/Aims: We explored Korean physicians' policies for surveillance of colorectal cancer (CRC) after curative surgery. Methods: Web-based self-report questionnaires were developed. Invitations to participate were emailed to physicians who diagnosed and treated CRC from October 1 to November 15, 2015. The questionnaire consisted of the role doctors played in the surveillance, examination of surveillance, and duration of postoperative surveillance according to CRC stage or primary site of the cancer. Results: Ninety-one physicians participated in the online survey, and 78 completed the survey. Sixty-seven participants (13%) answered "up to 5 years" for stage I surveillance duration; and 11 (13%) responded with a duration of > 5 years for stage I. A total of 61 (75%) responded with a surveillance duration of up to 5 years for stage II; and 19 (24%) responded with a duration of > 5 years for stage II. Sixty-seven (97%) and 61 (91%) physicians monitored patients with stage II/III every 3 or 6 months by laboratory examination and by abdominopelvic computed tomography scan for the first year, respectively. A total of 43 (53%) responded with a surveillance duration of up to 5 years for stage IV; and 46 (46%) responded with a duration of > 5 years for stage IV after curative resection. Conclusions: Korean physicians mostly followed up CRC using intensive postoperative surveillance. In preference to monitoring over a comparatively shorter period of time, the physicians tended to prefer monitoring patients post-operatively over a > 5 year period, particularly in cases of advanced-stage CRC.

Keywords

Acknowledgement

Supported by : Soonchunhyang University

References

  1. Jung KW, Won YJ, Kong HJ, et al. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2012. Cancer Res Treat 2015;47:127-141. https://doi.org/10.4143/crt.2015.060
  2. Primrose JN, Perera R, Gray A, et al. Effect of 3 to 5 years of scheduled CEA and CT follow-up to detect recurrence of colorectal cancer: the FACS randomized clinical trial. JAMA 2014;311:263-270. https://doi.org/10.1001/jama.2013.285718
  3. Rodriguez-Moranta F, Salo J, Arcusa A, et al. Postoperative surveillance in patients with colorectal cancer who have undergone curative resection: a prospective, multicenter, randomized, controlled trial. J Clin Oncol 2006;24:386-393. https://doi.org/10.1200/JCO.2005.02.0826
  4. Sargent D, Sobrero A, Grothey A, et al. Evidence for cure by adjuvant therapy in colon cancer: observations based on individual patient data from 20,898 patients on 18 randomized trials. J Clin Oncol 2009;27:872-877. https://doi.org/10.1200/JCO.2008.19.5362
  5. Cho YB, Chun HK, Yun HR, Lee WS, Yun SH, Lee WY. Clinical and pathologic evaluation of patients with recurrence of colorectal cancer five or more years after curative resection. Dis Colon Rectum 2007;50:1204-1210. https://doi.org/10.1007/s10350-007-0247-0
  6. Pita-Fernandez S, Alhayek-Ai M, Gonzalez-Martin C, Lopez-Calvino B, Seoane-Pillado T, Pertega-Diaz S. Intensive follow-up strategies improve outcomes in nonmetastatic colorectal cancer patients after curative surgery: a systematic review and meta-analysis. Ann Oncol 2015;26:644-656. https://doi.org/10.1093/annonc/mdu543
  7. Glimelius B, Tiret E, Cervantes A, Arnold D; ESMO Guidelines Working Group. Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2013;24 Suppl 6:vi81-vi88.
  8. Labianca R, Nordlinger B, Beretta GD, et al. Early colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2013;24 Suppl 6:vi64-vi72.
  9. Meyerhardt JA, Mangu PB, Flynn PJ, et al. Follow-up care, surveillance protocol, and secondary prevention measures for survivors of colorectal cancer: American Society of Clinical Oncology clinical practice guideline endorsement. J Clin Oncol 2013;31:4465-4470. https://doi.org/10.1200/JCO.2013.50.7442
  10. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in oncology: colon cancer. v2. 2016 [Internet]. Fort Washington (PA): National Comprehensive Cancer Network, c2017 [cited 2017 Aug 18]. Available from: https://www.nccn.org/professionals/physician_gls/f_guidelines.asp.
  11. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in oncology: rectal cancer. v1. 2016 [Internet]. Fort Washington (PA): National Comprehensive Cancer Network, c2017 [cited 2017 Aug 18]. Available from: https://www.nccn.org/professionals/physician_gls/f_guidelines.asp.
  12. Eisenberg B, Decosse JJ, Harford F, Michalek J. Carcinoma of the colon and rectum: the natural history reviewed in 1704 patients. Cancer 1982;49:1131-1134. https://doi.org/10.1002/1097-0142(19820315)49:6<1131::AID-CNCR2820490611>3.0.CO;2-T
  13. Shin A, Kim KZ, Jung KW, et al. Increasing trend of colorectal cancer incidence in Korea, 1999-2009. Cancer Res Treat 2012;44:219-226. https://doi.org/10.4143/crt.2012.44.4.219
  14. Seo SI, Lim SB, Yoon YS, et al. Comparison of recurrence patterns between $\leq$5 years and >5 years after curative operations in colorectal cancer patients. J Surg Oncol 2013;108:9-13. https://doi.org/10.1002/jso.23349
  15. Donadon M, Ribero D, Morris-Stiff G, Abdalla EK, Vauthey JN. New paradigm in the management of liver-only metastases from colorectal cancer. Gastrointest Cancer Res 2007;1:20-27.